2 results
Approved WMOPending
The effect of rLH for controlled ovarian hyperstimulation in order to achieve an increase of 10% in top quality embryos.
Approved WMORecruiting
Objective: To compare pembrolizumab plus paclitaxel with or without bevacizumab to placebo plus paclitaxel with or without bevacizumab, withrespect to progression-free survival (PFS) per RECIST 1.1 as assessed by the investigator.